These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 35063245)

  • 1. The effect of gastric acid suppression on probiotic colonization in a double blinded randomized clinical trial.
    Singh G; Haileselassie Y; Briscoe L; Bai L; Patel A; Sanjines E; Hendler S; Singh PK; Garud NR; Limketkai BN; Habtezion A
    Clin Nutr ESPEN; 2022 Feb; 47():70-77. PubMed ID: 35063245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The innovative potential of Lactobacillus rhamnosus LR06, Lactobacillus pentosus LPS01, Lactobacillus plantarum LP01, and Lactobacillus delbrueckii Subsp. delbrueckii LDD01 to restore the "gastric barrier effect" in patients chronically treated with PPI: a pilot study.
    Del Piano M; Anderloni A; Balzarini M; Ballarè M; Carmagnola S; Montino F; Orsello M; Pagliarulo M; Tari R; Soattini L; Sforza F; Mogna L; Mogna G
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S18-26. PubMed ID: 22955351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol of a randomized, double-blind, placebo-controlled study of the effect of probiotics on the gut microbiome of patients with gastro-oesophageal reflux disease treated with rabeprazole.
    Liu W; Xie Y; Li Y; Zheng L; Xiao Q; Zhou X; Li Q; Yang N; Zuo K; Xu T; Lu NH; Zhang H
    BMC Gastroenterol; 2022 May; 22(1):255. PubMed ID: 35596146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease.
    Shi YC; Cai ST; Tian YP; Zhao HJ; Zhang YB; Chen J; Ren RR; Luo X; Peng LH; Sun G; Yang YS
    Genomics Proteomics Bioinformatics; 2019 Feb; 17(1):52-63. PubMed ID: 31028880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitor-induced gut dysbiosis and immunomodulation: current knowledge and potential restoration by probiotics.
    Kiecka A; Szczepanik M
    Pharmacol Rep; 2023 Aug; 75(4):791-804. PubMed ID: 37142877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of Enterogermina's Protective and Restorative Mechanisms on the Gut Microbiota with PPI, Using SHIME Technology.
    Duysburgh C; Verstrepen L; Broeck MVD; Righetto Z; Perez M
    Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
    Freedberg DE; Kim LS; Yang YX
    Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors induced fungal dysbiosis in patients with gastroesophageal reflux disease.
    Shi Y; Li J; Cai S; Zhao H; Zhao H; Sun G; Yang Y
    Front Cell Infect Microbiol; 2023; 13():1205348. PubMed ID: 37662013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota indole-3-propionic acid mediates neuroprotective effect of probiotic consumption in healthy elderly: A randomized, double-blind, placebo-controlled, multicenter trial and in vitro study.
    Kim CS; Jung S; Hwang GS; Shin DM
    Clin Nutr; 2023 Jun; 42(6):1025-1033. PubMed ID: 37150125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors.
    Minalyan A; Gabrielyan L; Scott D; Jacobs J; Pisegna JR
    Curr Gastroenterol Rep; 2017 Aug; 19(8):42. PubMed ID: 28733944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effect of probiotics supplements in reflux esophagitis treated with esomeprazole: A randomized controlled trial.
    Sun QH; Wang HY; Sun SD; Zhang X; Zhang H
    World J Gastroenterol; 2019 May; 25(17):2110-2121. PubMed ID: 31114137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive Probiotics Alleviates Asthmatic Symptoms via Modulating the Gut Microbiome and Serum Metabolome.
    Liu A; Ma T; Xu N; Jin H; Zhao F; Kwok LY; Zhang H; Zhang S; Sun Z
    Microbiol Spectr; 2021 Oct; 9(2):e0085921. PubMed ID: 34612663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compared to histamine-2 receptor antagonist, proton pump inhibitor induces stronger oral-to-gut microbial transmission and gut microbiome alterations: a randomised controlled trial.
    Zhu J; Sun C; Li M; Hu G; Zhao XM; Chen WH
    Gut; 2024 Jun; 73(7):1087-1097. PubMed ID: 38050061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Influence of Proton Pump Inhibitors on the Fecal Microbiome of Infants with Gastroesophageal Reflux-A Prospective Longitudinal Interventional Study.
    Castellani C; Singer G; Kashofer K; Huber-Zeyringer A; Flucher C; Kaiser M; Till H
    Front Cell Infect Microbiol; 2017; 7():444. PubMed ID: 29075620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial.
    Oh B; Kim BS; Kim JW; Kim JS; Koh SJ; Kim BG; Lee KL; Chun J
    Helicobacter; 2016 Jun; 21(3):165-74. PubMed ID: 26395781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
    Abdul-Hussein M; Freeman J; Castell D
    Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Proton Pump Inhibitors on the Small Bowel and Stool Microbiomes.
    Weitsman S; Celly S; Leite G; Mathur R; Sedighi R; Barlow GM; Morales W; Sanchez M; Parodi G; Villanueva-Millan MJ; Rezaie A; Pimentel M
    Dig Dis Sci; 2022 Jan; 67(1):224-232. PubMed ID: 33534012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing.
    Dharmarajan TS
    J Am Med Dir Assoc; 2021 Jan; 22(1):15-22. PubMed ID: 33321078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volume, distribution and acidity of gastric secretion on and off proton pump inhibitor treatment: a randomized double-blind controlled study in patients with gastro-esophageal reflux disease (GERD) and healthy subjects.
    Steingoetter A; Sauter M; Curcic J; Liu D; Menne D; Fried M; Fox M; Schwizer W
    BMC Gastroenterol; 2015 Sep; 15():111. PubMed ID: 26328588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial.
    Bell R; Lipham J; Louie B; Williams V; Luketich J; Hill M; Richards W; Dunst C; Lister D; McDowell-Jacobs L; Reardon P; Woods K; Gould J; Buckley FP; Kothari S; Khaitan L; Smith CD; Park A; Smith C; Jacobsen G; Abbas G; Katz P
    Gastrointest Endosc; 2019 Jan; 89(1):14-22.e1. PubMed ID: 30031018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.